Table 1.
Laboratory test, median (1st–3rd quartiles) | Survivors (N = 798) | Non-survivors (N = 220) |
p value (age and sex adjusted) |
p value (fully adjusted) |
||
---|---|---|---|---|---|---|
Haemoglobin (g/L) | n = 739 | 13.0 (11.7–14.2) | n = 201 | 11.9 (10.3–13.2) | < 0.001 | 0.234 |
Lymphocytes (mm3) | n = 682 | 1055 (770–1450) | n = 186 | 790 (550–1030) | < 0.001 | < 0.001 |
Neutrophils (mm3) | n = 684 | 4475 (3020–6520) | n = 187 | 5960 (4055–9810) | < 0.001 | < 0.001 |
WBC (mm3) | n = 737 | 6180 (4770–8330) | n = 202 | 7475 (5530–10,840) | < 0.001 | < 0.001 |
Platelets (mm3) | n = 739 | 230.000 (170.000–291.000) | n = 201 | 196.000 (137.000–263.000) | 0.052 | 0.096 |
PT (INR) | n = 563 | 1.1 (1.0–1.2) | n = 150 | 1.2 (1.1–1.3) | 0.004 | 0.013 |
D-dimer (mg/L) | n = 434 | 855 (471–1656) | n = 119 | 1493 (953–3195) | < 0.001 | 0.006 |
LDH (IU/L) | n = 423 | 274 (215–356) | n = 119 | 405 (293–512) | < 0.001 | < 0.001 |
AST (IU/L) | n = 377 | 46 (30–74) | n = 92 | 55 (38–92) | 0.194 | 0.118 |
ALT (IU/L) | n = 610 | 37 (22–59) | n = 180 | 30 (18–46) | 0.663 | 0.606 |
C reactive protein (mg/L) | n = 654 | 6.1 (2.7–11.3) | n = 183 | 11.9 (7.0–18.4) | < 0.001 | < 0.001 |
IL-6 (pg/mL) | n = 154 | 25.2 (9.8–61.6) | n = 35 | 75.9 (37.8–137.4) | 0.004 | 0.016 |
Ferritin (ng/ml) | n = 318 | 754 (348–1397) | n = 96 | 843 (450–1544) | 0.119 | 0.013 |
Creatinine (mg/dL) | n = 718 | 0.9 (0.7–1.1) | n = 202 | 1.2 (0.9–1.9) | < 0.001 | < 0.001 |
Sodium (mmol/L) | n = 710 | 139 (137–141) | n = 193 | 140 (136–144) | 0.004 | 0.033 |
Potassium (mmol/L) | n = 699 | 4.1 (3.8–4.4) | n = 187 | 4.2 (3.7–4.6) | 0.116 | 0.306 |
Glycemia (mg/dL) | n = 612 | 105 (92–125) | n = 174 | 113 (93–152) | < 0.001 | 0.009 |
Fully adjusted: age, body temperature, heart rate, respiratory rate, systolic BP, diastolic BP, number of comorbidities, number of drugs, dementia, chronic heart failure, cancer, diabetes, COPD, asthma, previous myocardial infarction, previous stroke/TIA, atrial fibrillation, malnutrition